JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KIN
4076
DELISTED
Kindred Biosciences, Inc.
KIN
| $203K | ﹤0.01% |
45,277
+33,097
| +272% | +$148K |
2017 Q2
12 quarters
|
|
4077
BayCom
BCML
$339M
| $201K | ﹤0.01% |
15,606
-11,055
| -41% | -$137K |
2018 Q2
8 quarters
|
|
|
PRVB
4078
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $201K | ﹤0.01% |
+14,258
| New | +$180K |
2020 Q2
0 quarters
|
|
4079
ACNB Corp
ACNB
$649M
| $200K | ﹤0.01% |
7,667
-9,249
| -55% | -$229K |
2017 Q4
10 quarters
|
|
4080
Farmers & Merchants Bancorp
FMAO
$487M
| $200K | ﹤0.01% |
9,441
-5,877
| -38% | -$130K |
2017 Q4
10 quarters
|
|
4081
Geospace Technologies
GEOS
$61.4M
| $200K | ﹤0.01% |
26,548
-15,147
| -36% | -$101K |
2015 Q3
19 quarters
|
|
4082
Liquidia Corp
LQDA
$2.47B
| $200K | ﹤0.01% |
23,663
+15,785
| +200% | +$120K |
2018 Q3
7 quarters
|
|
|
STXB
4083
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $200K | ﹤0.01% |
16,299
-10,948
| -40% | -$124K |
2018 Q2
8 quarters
|
|
|
GLOG
4084
PUT
DELISTED
GASLOG LTD
GLOG
| $200K | ﹤0.01% |
71,000
| – | – |
2020 Q1
1 quarter
|
|
|
CRC
4085
DELISTED
California Resources Corporation
CRC
| $200K | ﹤0.01% |
164,366
-93,420
| -36% | -$158K |
2014 Q4
22 quarters
|
|
4086
Hingham Institution for Saving
HIFS
$624M
| $199K | ﹤0.01% |
1,182
-1,125
| -49% | -$175K |
2016 Q3
15 quarters
|
|
|
LOVE
4087
LoveSac
LOVE
$214M
| $199K | ﹤0.01% |
7,543
-76,898
| -91% | -$1.17M |
2018 Q3
7 quarters
|
|
|
GTT
4088
DELISTED
GTT Communications, Inc.
GTT
| $199K | ﹤0.01% |
24,389
-4,754
| -16% | -$42.9K |
2016 Q4
14 quarters
|
|
4089
Rocky Brands
RCKY
$346M
| $198K | ﹤0.01% |
9,694
-18,401
| -65% | -$366K |
2016 Q2
16 quarters
|
|
4090
CALL
Stoke Therapeutics
STOK
$1.63B
| $198K | ﹤0.01% |
+8,300
| New | +$197K |
2020 Q2
0 quarters
|
|
|
RBNC
4091
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $198K | ﹤0.01% |
12,207
+824
| +7% | +$11K |
2017 Q4
10 quarters
|
|
4092
KB Financial Group
KB
$43.8B
| $197K | ﹤0.01% |
7,086
+3,585
| +102% | +$98K |
2013 Q3
27 quarters
|
|
4093
LifeVantage
LFVN
$75.9M
| $197K | ﹤0.01% |
14,604
-11,171
| -43% | -$155K |
2016 Q4
14 quarters
|
|
4094
Alpha Metallurgical Resources
AMR
$2.2B
| $196K | ﹤0.01% |
64,680
+58,764
| +993% | +$211K |
2018 Q4
6 quarters
|
|
4095
Armstrong World Industries
AWI
$6.91B
| $196K | ﹤0.01% |
2,520
-647
| -20% | -$49K |
2015 Q1
21 quarters
|
|
|
WIFI
4096
DELISTED
Boingo Wireless, Inc.
WIFI
| $196K | ﹤0.01% |
14,754
+493
| +3% | +$6.45K |
2017 Q1
13 quarters
|
|
|
PACK.WS
4097
DELISTED
One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at
PACK.WS
| – | – |
0
| – | – |
2020 Q1
1 quarter
|
|
|
SLY
4098
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $196K | ﹤0.01% |
3,314
+293
| +10% | +$16K |
2018 Q4
6 quarters
|
|
4099
Corbus Pharmaceuticals
CRBP
$113M
| $195K | ﹤0.01% |
776
-7,069
| -90% | -$1.43M |
2017 Q4
10 quarters
|
|
|
GAN
4100
DELISTED
GAN Ltd
GAN
| $195K | ﹤0.01% |
+7,684
| New | +$147K |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.